NIH Invests $150 Million in Human-Based Research: Cell Culture and Animal Testing Alternatives
The future of biomedical research is evolving rapidly. In 2026, the National Institutes of Health (NIH) announced a $150 million investment to advance human based research technologies and reduce reliance on animal models [1].
This initiative reflects a growing focus on research methods that better replicate human biology while improving reproducibility and reducing ethical concerns. According to the NIH, animal models can have limitations in predicting human responses due to differences in physiology and disease progression [1].
As a result, researchers are increasingly turning to new approach methodologies, including organoids, tissue chips, and advanced cell culture systems.
The Growing Role of Cell Culture in Human Relevant Research
Human cell culture systems offer several advantages over traditional animal models:
- Improved relevance to human physiology
- Better reproducibility between experiments
- Reduced ethical concerns
- Faster experimental timelines
- Lower overall research costs
- Greater compatibility with high throughput screening and precision medicine applications
As research institutions continue investing in human-based methodologies, laboratories require reliable, scalable cell culture tools that support consistent experimental performance.
How Sterlitech Supports Human Based Research with cellQART®
Sterlitech supports the advancement of human based research with the cellQART product line, including cellQART Cell Culture Inserts and Well Plates designed to support modern in vitro workflows while aligning with 3Rs principle of reducing, refining, and replacing animal testing.
With cellQART Cell Culture Inserts, researchers can access high quality cell culture products that support human relevant research applications without the excessive costs often associated with traditional branded products.
As the NIH expands investment into new approach methodologies (NAMs) and human focused technologies, high quality cell culture systems will continue to play an increasingly important role in research involving:
- Drug discovery and development
- Toxicology studies
- Disease modeling
- Personalized medicine
- Regenerative medicine
- Organoid development
- issue engineering
Supporting the Future of Ethical and Predictive Research
NIH’s recent investment highlights a broader industry transformation toward research methods that better represent human biology while reducing animal use [1].
For researchers already adopting advanced cell culture methods, this shift validates years of innovation focused on improving scientific relevance and experimental efficiency. For others, it signals an opportunity to modernize laboratory workflows and explore technologies that align with the future of biomedical science.
Sterlitech remains committed to supporting this evolving research landscape by providing dependable cell culture and filtration solutions through the cellQART product line.
As human based research technologies continue to advance, laboratories equipped with scalable, high quality cell culture tools will be better positioned to drive innovation, accelerate discovery, and contribute to more predictive and ethical scientific outcomes.
Ask An Expert
As researchers continue adopting human relevant research methods, selecting the right cell culture tools is critical for achieving reliable and reproducible results.
Connect with Lexi Simpkins, Sterlitech's dedicated Bioprocessing and Cell Culture Specialist, to discuss your application and discover the cellQART® cell culture inserts and well plates best suited for your research needs.
Whether you're developing organoids, advancing drug discovery programs, conducting toxicology studies, or building more predictive in vitro models, Lexi can help identify cost effective cell culture solutions that support your workflow and research goals.
References
[1] National Institutes of Health (NIH). “NIH Invests $150 Million in Human Based Research to Reduce Use of Animal Models.” NIH Common Fund. https://commonfund.nih.gov/complementarie/news/nih-invests-150-million-human-based-research-reduce-use-animal-models
